PRECLINICAL STUDIES OF THE SPECIFIC ACTIVITY OF THE NEW ANTITUBERCULOSIS DRUG THIOZONIDE

In vitro and in vivo preclinical studies of the antituberculosis activity of thiozonide designed at the ZAO “Farn-Sintez” (Moscow) were conducted at the Central Research of Tuberculosis, Russian Academy of Medical Sciences. The in vitro study indicated that thiozonide exerted an antimycobacterial ef...

Full description

Bibliographic Details
Main Authors: I. V. Bocharova, M. S. Burenkov, L. N. Lepekha, T. G. Smirnova, L. N. Chernousova, O. V. Demikhova
Format: Article
Language:Russian
Published: NEW TERRA Publishing House 2014-06-01
Series:Tuberkulez i Bolezni Lëgkih
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/90